NCT04233580View on ClinicalTrials.gov

Characterization of AmnioExcel Plus in Two Treatment Paradigms

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

April 6, 2021

Study Completion Date

April 6, 2021

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Amnio Excel + weekly

Amnio Excel + weekly

DEVICE

Amnio Excel + max every 2 weeks

Amnio Excel + max every 2 weeks

Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas, Dallas

Sponsors
All Listed Sponsors
collaborator

Integra LifeSciences Corporation

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT04233580 - Characterization of AmnioExcel Plus in Two Treatment Paradigms | Biotech Hunter | Biotech Hunter